A detailed history of First Republic Investment Management, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 50,384 shares of DXCM stock, worth $4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,384
Holding current value
$4 Million
% of portfolio
0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$86.06 - $137.93 $4.34 Million - $6.95 Million
50,384 New
50,384 $4.7 Million
Q1 2023

May 11, 2023

BUY
$104.0 - $122.92 $68,224 - $80,635
656 Added 1.49%
44,699 $5.19 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $115,912 - $167,321
-1,364 Reduced 3.0%
44,043 $4.99 Million
Q3 2022

Nov 03, 2022

SELL
$76.35 - $94.18 $137,659 - $169,806
-1,803 Reduced 3.82%
45,407 $3.66 Million
Q2 2022

Aug 16, 2022

BUY
$67.99 - $132.89 $2.13 Million - $4.15 Million
31,258 Added 195.95%
47,210 $3.52 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $26,436 - $36,586
-281 Reduced 1.73%
15,952 $8.16 Million
Q4 2021

Feb 09, 2022

BUY
$129.87 - $162.82 $143,116 - $179,427
1,102 Added 7.28%
16,233 $8.72 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $153,875 - $206,465
1,442 Added 10.53%
15,131 $8.28 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $128,855 - $171,716
1,591 Added 13.15%
13,689 $5.85 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $39,681 - $49,018
-468 Reduced 3.72%
12,098 $4.35 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $131,742 - $176,500
1,689 Added 15.53%
12,566 $4.65 Million
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $643,832 - $761,395
6,741 Added 162.98%
10,877 $4.48 Million
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $63,870 - $107,341
1,019 Added 32.69%
4,136 $1.68 Million
Q1 2020

May 13, 2020

BUY
$47.79 - $75.63 $2,676 - $4,235
56 Added 1.83%
3,117 $839,000
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $17,650 - $27,613
-482 Reduced 13.6%
3,061 $670,000
Q3 2019

Nov 08, 2019

BUY
$35.53 - $43.8 $15,988 - $19,710
450 Added 14.55%
3,543 $529,000
Q2 2019

Aug 07, 2019

BUY
$27.84 - $38.92 $2,784 - $3,892
100 Added 3.34%
3,093 $463,000
Q1 2019

Apr 30, 2019

SELL
$28.07 - $38.18 $5,501 - $7,483
-196 Reduced 6.15%
2,993 $356,000
Q4 2018

Feb 12, 2019

BUY
$26.99 - $37.37 $4,588 - $6,352
170 Added 5.63%
3,189 $382,000
Q3 2018

Nov 13, 2018

SELL
$23.35 - $36.72 $1,517 - $2,386
-65 Reduced 2.11%
3,019 $432,000
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $54,093 - $77,778
3,084 New
3,084 $293,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.